SC 13D/A

AMENDMENT NO.14 TO SCHEDULE 13D

Company: Lineage Cell Therapeutics, Inc.
Filed: February 3, 2004
Accession Number: 0000950149-04-000255

View Document ↗ View on SEC.gov ↗